The use of porphyrins for eradication ofStaphylococcus aureusin burn wound infections (Q74429243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537756 AND SRC:MED&resulttype=core&format=json

10 November 2019

title

The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537756 AND SRC:MED&resulttype=core&format=json

10 November 2019

The use of porphyrins for eradication ofStaphylococcus aureusin burn wound infections (English)

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

eradication of infectious diseases

16 December 2024

main subject

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

A. Orenstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9537756

16 December 2024

D. Klein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9537756

16 December 2024

J. Kopolovic

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9537756

16 December 2024

E. Winkler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9537756

16 December 2024

Z. Malik

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9537756

16 December 2024

N. Keller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9537756

16 December 2024

Y. Nitzan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9537756

16 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9537756

16 December 2024

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537756 AND SRC:MED&resulttype=core&format=json

10 November 2019

December 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9537756

FEMS Immunology and Medical Microbiology

16 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537756 AND SRC:MED&resulttype=core&format=json

10 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537756 AND SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537756 AND SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

307-314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537756 AND SRC:MED&resulttype=core&format=json

Topical therapy for burns

10 November 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Infection and antibiotic therapy in 4000 burned patients treated in Milan, Italy, between 1976 and 1988.

16 December 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection

16 December 2024

5

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management

16 December 2024

7

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Bactericidal effects of photoradiation therapy with hematoporphyrin derivative

16 December 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Collapse of K and ionic balance during photodynamic inactivation of leukemic cells, erythrocytes and Staphylococcus aureus

16 December 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Structure-activity relationship of porphines for photoinactivation of bacteria.

16 December 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

The bactericidal activity of a deuteroporphyrin-hemin mixture on gram-positive bacteria. A microbiological and spectroscopic study

16 December 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Deep partial skin thickness burns: a reproducible animal model to study burn wound healing

16 December 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

The changing epidemiology of infection in burn patients

16 December 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

The epidemiology of methicillin-resistant Staphylococcus aureus in a burn center.

16 December 2024

18

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Surgical Patients With Multiantibiotic‐Resistant Bacteria

16 December 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Methicillin-resistant Staphylococcus aureus eradication in a burn center.

16 December 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Bactericidal effects of photoactivated porphyrins--an alternative approach to antimicrobial drugs

16 December 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection

16 December 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Comparison of silver sulphadiazine 1 per cent, silver sulphadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent and mafenide acetate 8.5 per cent for topical antibacterial effect in infected full skin thickness rat burn wounds

16 December 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Comparison of 1% silver sulfadiazine with and without 1% chlorhexidine digluconate for topical antibacterial effect in the burnt infected rat.

16 December 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

Comparison of silver sulfadiazine 1% with chlorhexidine digluconate 0.2% to silver sulfadiazine 1% alone in the prophylactic topical antibacterial treatment of burns

16 December 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1574-695X.1997.TB01101.X

16 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9537756 AND SRC:MED&resulttype=core&format=json

10 November 2019

1 reference